Featured live and on-demand webinars, with experts presenting on the most relevant topics for Bronchiectasis. 

Access the Enduring Webinar Here
 
Are you going to be at ATS 2025? Visit us for this live presentation on: 

Sunday, May 18, 2025 - 12:15-1:15PM - Location Forthcoming 

Presenters: 

Anne O’Donnell, MD 
Division Chief of Pulmonary Medicine, 
Critical Care, and Sleep Medicine Medical Director of the Sleep Disorders Center  
Georgetown University 
Medstar Health 
Washington. D.C. 
Click for biography 

Chris Richards, MD 
Instructor in Medicine 
Department of Medicine 
Massachusetts General Hospital 
Boston, MA 
Click for biography 

 

Bronchiectasis is a chronic and progressive lung disease characterized by permanent airway dilation, recurrent infections, and progressive lung damage. Despite its significant burden, bronchiectasis remains underdiagnosed and mismanaged, leading to frequent exacerbations, hospitalizations, and declining lung function. This educational session will provide clinicians with a comprehensive understanding of bronchiectasis, focusing on early identification, disease progression, and evolving treatment strategies. Participants will first explore the clinical presentation and diagnostic criteria to enhance recognition and reduce misdiagnosis (LO1). The session will then examine the impact of pulmonary exacerbations on bronchial remodeling and disease progression, emphasizing the need for timely intervention to prevent further lung damage (LO2). Finally, faculty will review the current treatment landscape, highlighting standard management approaches and the critical unmet need for targeted therapies (LO3). With no approved therapies specifically for bronchiectasis, this session will equip healthcare providers with essential knowledge to optimize patient care while anticipating advancements in treatment. 


The planners for this session are: 

 Asha Anandaiah, MD, Harvard Medical School 

Mark L. Metersky, MD, University of Connecticut School of Medicine 

B. Shoshana Zha, MD, PhD, University of California-San Francisco 

  

This program was produced in collaboration with Insmed Incorporated. 

Objectives 

  • recognize the clinical presentation and diagnostic criteria for bronchiectasis to improve identification and reduce misdiagnosis 

  • assess the impact of pulmonary exacerbations on bronchial remodeling and disease progression in bronchiectasis 

  • evaluate the current treatment landscape for bronchiectasis, including existing management strategies and unmet therapeutic needs